Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease

(1) Background: Parkinson’s disease (PD) is a progressively worsening neurodegenerative disorder affecting movement, mental well-being, sleep, and pain. While no cure exists, treatments like hyperbaric oxygen therapy (HBOT) offer potential relief. However, the molecular biology perspective, especial...

Full description

Bibliographic Details
Main Authors: Eirini Banou, Aristidis G. Vrahatis, Marios G. Krokidis, Panagiotis Vlamos
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:BioMedInformatics
Subjects:
Online Access:https://www.mdpi.com/2673-7426/4/1/9
_version_ 1797241964063621120
author Eirini Banou
Aristidis G. Vrahatis
Marios G. Krokidis
Panagiotis Vlamos
author_facet Eirini Banou
Aristidis G. Vrahatis
Marios G. Krokidis
Panagiotis Vlamos
author_sort Eirini Banou
collection DOAJ
description (1) Background: Parkinson’s disease (PD) is a progressively worsening neurodegenerative disorder affecting movement, mental well-being, sleep, and pain. While no cure exists, treatments like hyperbaric oxygen therapy (HBOT) offer potential relief. However, the molecular biology perspective, especially when intertwined with machine learning dynamics, remains underexplored. (2) Methods: We employed machine learning techniques to analyze single-cell RNA-seq data from human PD cell samples. This approach aimed to identify pivotal genes associated with PD and understand their relationship with HBOT. (3) Results: Our analysis indicated genes such as MAP2, CAP2, and WSB1, among others, as being crucially linked with Parkinson’s disease (PD) and showed their significant correlation with Hyperbaric oxygen therapy (HBOT) indicatively. This suggests that certain genomic factors might influence the efficacy of HBOT in PD treatment. (4) Conclusions: HBOT presents promising therapeutic potential for Parkinson’s disease, with certain genomic factors playing a pivotal role in its efficacy. Our findings emphasize the need for further machine learning-driven research harnessing diverse omics data to better understand and treat PD.
first_indexed 2024-04-24T18:31:41Z
format Article
id doaj.art-d62c610805d841dea320ea41041eed9b
institution Directory Open Access Journal
issn 2673-7426
language English
last_indexed 2024-04-24T18:31:41Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series BioMedInformatics
spelling doaj.art-d62c610805d841dea320ea41041eed9b2024-03-27T13:27:28ZengMDPI AGBioMedInformatics2673-74262024-01-014112713810.3390/biomedinformatics4010009Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s DiseaseEirini Banou0Aristidis G. Vrahatis1Marios G. Krokidis2Panagiotis Vlamos3Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, GreeceBioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, GreeceBioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, GreeceBioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, Greece(1) Background: Parkinson’s disease (PD) is a progressively worsening neurodegenerative disorder affecting movement, mental well-being, sleep, and pain. While no cure exists, treatments like hyperbaric oxygen therapy (HBOT) offer potential relief. However, the molecular biology perspective, especially when intertwined with machine learning dynamics, remains underexplored. (2) Methods: We employed machine learning techniques to analyze single-cell RNA-seq data from human PD cell samples. This approach aimed to identify pivotal genes associated with PD and understand their relationship with HBOT. (3) Results: Our analysis indicated genes such as MAP2, CAP2, and WSB1, among others, as being crucially linked with Parkinson’s disease (PD) and showed their significant correlation with Hyperbaric oxygen therapy (HBOT) indicatively. This suggests that certain genomic factors might influence the efficacy of HBOT in PD treatment. (4) Conclusions: HBOT presents promising therapeutic potential for Parkinson’s disease, with certain genomic factors playing a pivotal role in its efficacy. Our findings emphasize the need for further machine learning-driven research harnessing diverse omics data to better understand and treat PD.https://www.mdpi.com/2673-7426/4/1/9Parkinson’s diseasehyperbaric oxygen therapymachine learninggenomic factorssingle-cell RNA-seq
spellingShingle Eirini Banou
Aristidis G. Vrahatis
Marios G. Krokidis
Panagiotis Vlamos
Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
BioMedInformatics
Parkinson’s disease
hyperbaric oxygen therapy
machine learning
genomic factors
single-cell RNA-seq
title Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
title_full Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
title_fullStr Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
title_full_unstemmed Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
title_short Machine Learning Analysis of Genomic Factors Influencing Hyperbaric Oxygen Therapy in Parkinson’s Disease
title_sort machine learning analysis of genomic factors influencing hyperbaric oxygen therapy in parkinson s disease
topic Parkinson’s disease
hyperbaric oxygen therapy
machine learning
genomic factors
single-cell RNA-seq
url https://www.mdpi.com/2673-7426/4/1/9
work_keys_str_mv AT eirinibanou machinelearninganalysisofgenomicfactorsinfluencinghyperbaricoxygentherapyinparkinsonsdisease
AT aristidisgvrahatis machinelearninganalysisofgenomicfactorsinfluencinghyperbaricoxygentherapyinparkinsonsdisease
AT mariosgkrokidis machinelearninganalysisofgenomicfactorsinfluencinghyperbaricoxygentherapyinparkinsonsdisease
AT panagiotisvlamos machinelearninganalysisofgenomicfactorsinfluencinghyperbaricoxygentherapyinparkinsonsdisease